21 CFR 522.2002

§ 522.2002 Propiopromazine.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 522.2002, § 522.2002 Propiopromazine, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87524
Permanent ID: ys:prov:87524@1
SHA-256: 16b72f631f41f080b8062dc107433e457322c57a0a1d64e3e9066505cb84e432

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of solution contains 5 or 10 milligrams (mg) propiopromazine hydrochloride. (b) Sponsor. See No. 054771 in § 510.600(c) of this chapter. (c) Conditions of use in dogs and cats—(1) Amounts and indications for use. Administer 0.05 to 0.5 mg per pound of body weight by intravenous or intramuscular injection for tranquilization. Administer 0.25 mg per pound of body weight by intravenous injection as a preanesthetic. (2) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.